Hiroshi Mukae, M.D., Ph.D.

Professor
Nagasaki University, Japan

Disclosure(s): AstraZeneca: Lecture fees; Gilead Sciences: Lecture fees; GSK: Lecture fees; MSD: Advisor/Consultant, Lecture fees; Pfizer: Lecture fees; Shionogi & Co., Ltd.: Advisor/Consultant, Grant/Research Support, Lecture fees

Poster(s):

(P-311) Shifts in Methicillin-Resistant Staphylococcus aureus Types in Bloodstream Infections: Nationwide and Regional Influences and Their Impact on Mortality

Thursday, October 17, 2024
12:15 PM – 1:30 PM US PT
(P-793) Long-term Outcomes of Mycobacterium avim complex Pulmonary Disease in Kyushu, Japan: A Retrospective Multicenter Study

Thursday, October 17, 2024
12:15 PM – 1:30 PM US PT
(P-875) Bacteroides spp. drug resistance in patients with anaerobic bacteremia: a multicentric retrospective observational study

Friday, October 18, 2024
12:15 PM – 1:30 PM US PT
(P-1534) The Impact of Broad-spectrum Antimicrobials in Patients with Community-onset Pneumonia at Low Risk of Drug-resistant Pathogens: A Historical Cohort Study

Friday, October 18, 2024
12:15 PM – 1:30 PM US PT
(P-2044) Analysis of Post COVID-19 Condition After Ensitrelvir Treatment in Asymptomatic or Mild-Symptoms Only Patients in the SCORPIO Phase2b/3 Study

Saturday, October 19, 2024
12:15 PM – 1:30 PM US PT
(P-2140) Clinical Review of Respiratory Tract Infections Caused by Exophiala dermatitidis Misidentified as genus Rhodotorula: Case Series.

Saturday, October 19, 2024
12:15 PM – 1:30 PM US PT